Clinical Trial

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-06.
Trial Details
NCT Number NCT07022470
Lead Sponsor Stanford University
Conditions Cervical Cancers
Enrollment 41 participants
Start Date 2025-06-03
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-12